Typbar TCV is a Typhoid vaccine, it is developed by Bharat Biotech. It is world’s first typhoid vaccine which is clinically proven and can be given to children from six months to adults.

• And it also ensures to control long term protection from typhoid fever.
• Conjugate vaccine is the vaccine in which the Antigen(Polysaccharide) is linked to carrier protein. A single dose of vaccine was found to be effective and it is shown around 82% efficacy in preventing typhoid fever.
• WHO – Strategic Advisory Group of  Experts on Immunization(WHO-SAGE) is recommended Typbar TCV vaccine in 2017 and the vaccine is prequalified by WHO in 2018.
• Pakistan is the first country to use WHO approved typhoid vaccine as part of their National Immunisation programme.

Typhoid:

Typhoid fever is caused by Salmonella Typhi bacteria, which is highly contagious and it spread through contaminated food or water. According to WHO report, Children below 2 years of age is more vulnerable to severe Typhoid fever. According to WHO, in 2017, around 70% of deaths among children in the world is due to Typhoid.

Symptoms of  Typhoid:

• Prolonged fever
• Headache
• Nausea
• loss of appetitE
• constipation.